VYNE THERAPEUTICS INC's ticker is VYNE and the CUSIP is 92941V209. A total of 2 filers reported holding VYNE THERAPEUTICS INC in Q1 2023. The put-call ratio across all filers is - and the average weighting 0.0%.
Quarter-by-quarter ownership
Value | Shares | Weighting | ||||
---|---|---|---|---|---|---|
Q4 2022 | $4,500 | -35.7% | 30,000 | 0.0% | 0.00% | -50.0% |
Q3 2022 | $7,000 | -41.7% | 30,000 | 0.0% | 0.00% | -33.3% |
Q2 2022 | $12,000 | -40.0% | 30,000 | 0.0% | 0.00% | 0.0% |
Q1 2022 | $20,000 | -35.5% | 30,000 | 0.0% | 0.00% | -40.0% |
Q4 2021 | $31,000 | -26.2% | 30,000 | 0.0% | 0.01% | -16.7% |
Q3 2021 | $42,000 | -96.9% | 30,000 | -92.2% | 0.01% | -96.8% |
Q2 2021 | $1,357,000 | -55.1% | 386,491 | -12.5% | 0.19% | -58.5% |
Q1 2021 | $3,022,000 | – | 441,491 | – | 0.45% | – |
Download |
Other shareholders
Name | Shares | Value | Weighting ↓ |
---|---|---|---|
DSC Advisors, L.P. | 2,551,000 | $2,602,000 | 2.01% |
Perceptive Advisors | 4,356,044 | $4,444,000 | 0.03% |
GSA CAPITAL PARTNERS LLP | 217,747 | $222,000 | 0.03% |
Virtu Financial LLC | 175,278 | $179,000 | 0.02% |
XTX Topco Ltd | 17,053 | $17,000 | 0.01% |
SkyOak Wealth, LLC | 27,200 | $28,000 | 0.01% |
DELTEC ASSET MANAGEMENT LLC | 30,000 | $31,000 | 0.01% |
Tekla Capital Management LLC | 135,395 | $138,000 | 0.00% |
STALEY CAPITAL ADVISERS INC | 62,500 | $64,000 | 0.00% |
TWO SIGMA SECURITIES, LLC | 47,475 | $48,000 | 0.00% |